Articles

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma

Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA
Department of Neuro-Oncology, Daniel den Hoed Cancer Center, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA
Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA
Department of Medicine and Centro de Investigacion del Cancer (IBMCC-CSIC/USAL) and Department of Hematology, University Hospital, IBSAL and University of Salamanca, Salamanca, Spain
Department of Medicine and Centro de Investigacion del Cancer (IBMCC-CSIC/USAL) and Department of Hematology, University Hospital, IBSAL and University of Salamanca, Salamanca, Spain
Department of Hematology, Hospital German Trias i Puyol, University of Barcelona, Spain for the Spanish Group for the Study of CNS Disease in NHL
Department of Medicine and Centro de Investigacion del Cancer (IBMCC-CSIC/USAL) and Department of Hematology, University Hospital, IBSAL and University of Salamanca, Salamanca, Spain
Department of Hematology, Daniel den Hoed Cancer Center, Erasmus MC, University Medical Center Rotterdam, The Netherlands
Department of Medical Immunology, Daniel den Hoed Cancer Center, Erasmus MC, University Medical Center Rotterdam, The Netherlands
Department of Hematology, Hospital del Mar, Barcelona, Spain
Department of Hematology, Hospital del Mar, Barcelona, Spain
Department of Hematology, Hospital Duran i Reynals, Institut Catala d’Oncologia, IDIBELL, University of Barcelona, Spain
Department of Hematology, Hospital German Trias i Puyol, University of Barcelona, Spain for the Spanish Group for the Study of CNS Disease in NHL
Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA
Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA
Lymphoid Malignancy Branch, National Cancer Institute, Bethesda, MD, USA
Mundipharma International Limited, Cambridge, UK
Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
Department of Medicine and Centro de Investigacion del Cancer (IBMCC-CSIC/USAL) and Department of Hematology, University Hospital, IBSAL and University of Salamanca, Salamanca, Spain
Vol. 99 No. 7 (2014): July, 2014 https://doi.org/10.3324/haematol.2013.101741